Does more virtual care mean more low-value care? Study suggests no
Peer-Reviewed Publication
Updates every hour. Last Updated: 6-May-2025 13:09 ET (6-May-2025 17:09 GMT/UTC)
New recommendations from DEFRA’s Hazardous Substances Advisory Committee (HSAC) have set out steps that could make the UK a world leader in more ethical, safer, and cost-effective chemical testing, through early adoption of a risk-based approach to regulation (also called next generation risk assessment).
AI-powered apps offering medical diagnoses at the click of a button are often limited by biased data and a lack of regulation, leading to inaccurate and unsafe health advice, a new study found.
McGill University researchers presented symptom data from known medical cases to two popular, representative apps to see how well they diagnosed the conditions. While the apps sometimes gave correct diagnoses, they often failed to detect serious conditions, according to findings published in the Journal of Medical Internet Research. This potentially resulted in delayed treatment.
A new study published in the SCI journal Pest Management Science sheds light on the behaviour of grey squirrels (Sciurus carolinensis) and explores methods for the targeted delivery of oral contraceptives to control their populations. The research, a collaboration between APHA's National Wildlife Management Centre, Durham University, and the University of York, provides a platform for mitigating the environmental damage caused by this invasive species and protecting the UK’s declining native red squirrel (Sciurus vulgaris) population.
Sylvain Bouix, from École de technologie supérieure (ÉTS), Martha E. Shenton and Ofer Pasternak, from the Brigham and Women’s Hospital (Harvard University), and René Kahn, from Mount Sinai Hospital (New York) has just received US $33 million in funding—the equivalent of CAD 45 million—over five years from the National Institute of Mental Health to better understand the mechanisms of action of new drugs designed to treat psychosis.
Kidney disease is a global health concern, but conventional tests that check creatinine levels often overlook early signs of damage. To solve this, researchers developed an innovative biosensor that detects symmetric dimethylarginine (SDMA), a byproduct of protein breakdown. The sensor uses special peptides to measure SDMA in urine with high accuracy and does not need additional diagnostic equipment. This simple, cost-effective tool enables early detection of kidney issues, supporting timely interventions and improved patient outcomes.